October 14th 2024
The Big Pharma commercialization playbook doesn’t work for emerging life sciences companies bootstrapping their way up. Exploring three strategies that could be the ingredients of a winning formula for startups.
Biopharma Market Access: The Pivot to Payer Omnichannel Engagement
November 1st 2021Prior to 2019, research indicated that payers across markets used a range of digital information sources to support their decision making and to keep abreast of medical news. But COVID-19 sparked an uptick in interest from global and US market access teams for an omnichannel approach.
The Enduring Value of Pharma/Biotech Hybrid Sales Teams
October 26th 2021The increased interest from HCPs to implement more virtual communication with sales representatives highlights the importance of the hybrid sales model. Competition is fierce - how does one hybrid team distinguish itself and stand out from the crowd to find success for the company?
Stumped in Your Sales Calls with Healthcare Providers? Ask These 6 Trust-Building Questions
October 15th 2021Erica Schultz, CMO of RAIN Group, provides insight on how to breakthrough to make connections and build rapport with HCPs in a time when face-to-face and other interactions have decreased significantly.
Fishawack Health appoints new CEO, Jonathan Koch
October 5th 2021Jonathan Koch will lead the commercialization partner through its next stage of growth, centered on building and retaining talented teams and delivering a full set of integrated services for our clients across the life science industry.
Margot Hannah Appointed New Chief Executive Officer of OPEN Health Communications
September 29th 2021With her new appointment as CEO, Margaret Hannah will be responsible for more than 500 people, with overall accountability for the Medical and Brand Communications services - including publications, medical education, learning and development, and creative and digital services.
The Untapped Potential of Behavioral Science in Medical Affairs
September 29th 2021Historically, Medical Affairs teams have relied on reporting only empirical evidence such as efficacy and tolerability profiles to influence uptake of a new drug or therapy. Here, Ben Routley and Mark Pringle explore the scope for applying behavioral science techniques to improve the impact of client communications.
Changing CME: Q&A with Diane Bartoli, VP & GM, epocrates
September 20th 2021Since the beginning of institutionalized medical instruction, CME has always been beneficial to help those in the medical industry retain proficiency and learn about new and developing areas of their fields. The COVID-19 pandemic has highlighted the need for additional digital content for HCPs, both out of necessity and preference.
Sales: Developing Critical “Soft Skills” with Training Simulations
September 17th 2021”Soft skills” are notoriously difficult to teach. For that reason, many trainers are applying state-of-the-art computer simulations to help develop these skills within pharma sales organizations, writes Jeremy Lovelace.